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Abstract
Based on genotyping and host range, two newly isolated lytic bacteriophages, myovirus vB_AbaM_Acibel004 and
podovirus vB_AbaP_Acibel007, active against Acinetobacter baumannii clinical strains, were selected from a new phage
library for further characterization. The complete genomes of the two phages were analyzed. Both phages are characterized
by broad host range and essential features of potential therapeutic phages, such as short latent period (27 and 21 min,
respectively), high burst size (125 and 145, respectively), stability of activity in liquid culture and low frequency of
occurrence of phage-resistant mutant bacterial cells. Genomic analysis showed that while Acibel004 represents a novel
bacteriophage with resemblance to some unclassified Pseudomonas aeruginosa phages, Acibel007 belongs to the well-
characterized genus of the Phikmvlikevirus. The newly isolated phages can serve as potential candidates for phage cocktails
to control A. baumannii infections.
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Introduction
Multidrug-resistant (MDR) Acinetobacter baumannii is a rela-
tively newly emerged pathogen, notorious for its role in
nosocomial wound infections [1–3]. The ability to form biofilms
and extended survival on environmental surfaces along with broad
resistance to antibiotics puts A. baumannii on the list of the
medically most important pathogens [4]. The known risk factors
for A. baumannii colonization or infection include prolonged
hospitalization, intensive care unit (ICU) admission, recent
surgical procedures, parenteral nutrition, invasive procedures,
nursing home residence, and previous broad-spectrum antibiotic
use [5–9].
In comparison to other clinically relevant bacteria, Acinetobac-
ter spp. can develop antibiotic resistance extremely rapidly due to
long-term evolutionary exposure to soil organisms that produce
antibiotics [10]. Many A. baumannii strains are characterized by
an impressive number of acquired mechanisms of resistance to
antibiotics, including enzymatic inactivation, modification of
target sites, active efflux and decreased influx of drugs [11]. In
addition, A. baumannii has a naturally occurring ‘‘blaOXA-51-like’’
carbapenem-hydrolyzing class D b-lactamase (CHDL) gene,
intrinsic to this species, although phenotypic resistance is not
associated only with the presence of this gene and normally
depends on other genetic determinants as well [12].
Treatment of MDR strains of A. baumannii is a challenging
issue for modern medicine. Carbapenems are the antibiotics of the
first choice against multidrug resistant A. baumannii infections.
However, carbapenem-resistant A. baumanniii are being increas-
ingly reported worldwide [6,13]. Other therapeutic options
include sulbactam, aminoglycosides, polymyxins and tigecycline.
Recently, high resistance rates to tigecycline and polymyxins were
also reported [14–16].
Bacteriophages active against MDR strains of A. baumannii
could be considered as a potential solution to meet the challenges
posed by this pathogen. Indeed, a number of new phages carrying
potential to combat infections caused by A. baumannii strains have
been recently reported [17–24].
In our study, we isolated and characterized two highly lytic
bacteriophages: myovirus vB_AbaM_Acibel004 and podovirus
vB_AbaP_Acibel007 (from here on shortened to Acibel004 and
Acibel007, respectively), named in accordance with the proposed
nomenclature for bacteriophages by Kropinski et al. [25]. The
phages were characterized, according to criteria considered as
essential for potential therapeutic phages and both phages proved
to meet all of them.
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Materials and Methods
Bacterial strains
In total, 34 strains of Acinetobacter spp. were used in the study
(Table S1). Twenty one A. baumannii, three A. pittii and one A.
nosocomialis strains were isolated from successive outbreaks in the
Burn Wound Center of the Queen Astrid Military Hospital
(Brussels, Belgium). Eight strains were received from Leiden
University Medical Center, the Netherlands: one A. pittii strain,
one A. nosocomialis strain and six A. baumannii strains including
representatives of European epidemic clones I, II and III. The A.
baumannii T strain NCTC 13423 was obtained from Public
Health England, UK [12]. Initial identification and antibiotic
susceptibility profile detection of the strains were performed by the
VITEK 2 system (BioMe´rieux, France) using ASTN155 card for
Gram-negative bacteria. For the precise identification, partial
sequencing of the rpoB gene was performed [26]. All strains were
typed by rep-PCR using the DiversiLab Acinetobacter 3.4 kit
(BioMe´rieux, France). A cluster of closely related isolates was
defined as isolates sharing $95% similarity [27]. All strains were
screened for the presence of blaOXA-51-like and blaOXA-23-like
carbapenemases encoding genes in their genomes by Multiplex-
PCR (M-PCR) [28].
Phage isolation, purification and propagation
Ghent University Hospital (GUH) waste water samples were
used for isolation of active phages by culture-enrichment method
described in Merabishvili et al. [29], with slight modifications.
Briefly, 15 ml of 106 concentrated LB broth (Becton Dickinson,
Erembodegem, Belgium) was mixed with 135 ml sample water
and 1 ml (108 cfu/ml) of one/different combinations of test strains
in a 200 ml bottle. The mixture was incubated at 32uC overnight.
Subsequently, 3 ml of chloroform was added and the bottle was
further incubated at 4uC for 2 h. The parallel streaks and agar-
overlay methods [29] were used to check the lysates for the
presence of phages and subsequent isolation of pure phage
particles. Plaques with different morphology were touched with a
sterile pipette tip, inoculated into 2 ml of sterile LB broth and
incubated at 37uC for 2 h. Each phage separation procedure was
repeated 10 times to ensure single phage suspensions.
High titer bacteriophage stocks were prepared by the agar
overlay method [29]. The A. baumannii strain 070517/0072
served as a host strain for the propagation of the Acibel004 and
Acibel007 phages. Further phage particles in the obtained lysates
were precipitated using PEG 8000 (8%, wt/vol) + 1 M NaCl
according to Sambrook and Russel [30]. Phages for proteomic
analysis were purified by centrifugation in CsCl gradients at
140,0006g for 3 h [30].
Host range analysis and determination of Efficiency of
Plating (EOP)
The parallel streaks method [29] was used to detect the
susceptibility of the 34 bacterial strains for the two phages. All
susceptible strains revealed by the parallel streaks method were
titered against the phages to detect the EOP and the ability of the
phage to propagate in the strain. EOP was calculated as the ratio
of titer on the test strain to the titer on the host strain.
Transmission electron microscopy
Bacteriophage particles were analyzed by transmission electron
microscopy as described by Imberechts et al. [31]. Briefly,
suspensions were brought on carbon and pioloform-coated grids
(Agar Scientific, Stansted, UK), washed with water and negatively
stained with 2% uranyl acetate (Agar Scientific) in water and
analyzed using a Technai Spirit transmission electron microscope
(FEI, Eindhoven, The Netherlands), operating at 120 kV.
Micrographs were recorded using a bottom-mounted digital
camera (Eagle, 4X4K, FEI).
Phage adsorption and one-step growth parameters
Exponentially grown A. baumannii 070517/0072 cells were
mixed with each phage at a MOI of 0.001 and incubated at 37uC.
Aliquots of 50 ml were removed after 3, 5, 8, 10, 15 and 20 min
and diluted 100 times in 4.45 ml LB broth and 0.5 ml chloroform.
The tubes were incubated for 30 min at room temperature and
subsequently titrated to detect the number of non-adsorbed
phages. The rate of adsorption was determined according to
Adams [32]. The adsorption curves were constructed based on the
ratio of non-adsorbed phage at different time intervals over the
initial phage number.
In the one-step growth experiment, A. baumannii 070517/0072
(108 cfu/ml) was infected with each phage at a MOI of 0.001. The
adsorption process was allowed to occur during 8 min at 37uC.
The mixture was centrifuged (13,0006g, 1 min), and the pellet
resuspended in 10 ml of fresh LB broth and incubated for 1.5 h at
37uC. The samples were taken at intervals of 3 minutes and
titrated. The latent period was defined as the interval between
adsorption of the phages to the bacterial cells and the release of
phage progeny. The burst size of the phage was determined as the
ratio of the final number of free phage particles to the number of
infected bacterial cells during the latent period.
Frequency of occurrence of phage-resistant mutant
bacterial cells
The frequency of occurrence of phage-resistant mutant bacterial
cells was detected by the method described in Adams [32]. Briefly,
1 ml of bacterial culture at the concentration of 108 cfu/ml was
mixed with the appropriate volume of phage lysate at a MOI of
100. After 10 min of incubation at 37uC, 100 ml of the mixture
was spread on LB plates and phage-resistant colonies were
enumerated after overnight incubation at 32uC. The emerged
colonies were isolated twice to assure phage-free bacterial cultures.
Further the isolated bacterial cultures were tested against phages
by parallel streaks method to confirm their true resistance. The
experiments were performed in triplicate and mean values
calculated.
Stability of phage activity in broth culture
Stability of the activity of each phage separately and in mixture
with the other phage in LB broth was studied according to the
method of Appelmans [32]. Briefly, serial tenfold dilutions of each
phage and of the mixture of phages, with initial concentration of
109 pfu/ml, were prepared in 5 ml LB broth starting from 1022
dilution. A. baumannii 070517/0072 bacterial culture was added
to each dilution with a final concentration of 105 cfu/ml, thereby
multiplicity of infection (MOI) ranged from 100 to 0.00001.
Bacterial growth and phage activity was monitored by measuring
OD600 after 24 and 48 h of incubation at 37uC.
Fluorescent RFLP analysis of phage genome
fRFLP analysis on phage genomes was performed according to
Merabishvili et al. [34] with slight modifications: fluorescent
primer HhaI+O was labeled with FAM (5-carboxyfluorescein)
and PCR products were analyzed in ABI 3130xl Genetic
Analyzer. Comparison of digitized fingerprints was carried out
by the in-house program Basehopper, available at www.
basehopper.be. A similarity tree was constructed by Neighbor
Two Novel Phages of A. baumannii
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joining using the programs PHYLIP [http://evolution.genetics.
washington.edu/phylip.html] and TreeView [http://taxonomy.
zoology.gla.ac.uk/rod/treeview.html].
DNA sequencing and genome annotation
DNA from high titer phage stocks was isolated by the classic
phenol-chloroform extraction method, according to Sambrook &
Russell [30]. The procedure was preceded by DNase I and RNase
A treatment at the concentrations of 10 mg/ml and 55 mg/ml,
respectively, to remove bacterial nucleic acids. The sequences
were determined by pyrosequencing (454 technology). ORF
2013], GeneMark [35] and Glimmer [36,37] were used to predict
open reading frames (ORFs) in the phage genomes. Putative
functions were assigned to the corresponding gene products based
on the results of a protein BLAST (version 2.2.26) [38,39] and
HHpred [40]. The search for signal peptide cleavage sites and
transmembrane helices was performed using SignalP (4.1) [41]
and TMHMM (2.0) [42], respectively. The presence of tRNA-
encoding genes was determined by Aragorn (1.2.36) [43] and
tRNAscan-SE (1.21) [44]. Conserved regulatory elements, such as
putative host- and phage-specifc promoters and Rho-factor
independent terminators were searched by MEME/MAST
(4.9.0) [45], ARNOLD [46,47] and PHIRE [48]. All these steps
were followed by manual verification. Promoters were evaluated
on the presence of consensus sequences at 235 and 210
upstream, terminators were scored based on the presence of a
strong palindromic sequence, followed by a U-rich stretch and an
estimated free energy value for stem-loop formation of 28 at max.
Based on the annotated phage genomes, GenBank files were
created with Sequin [www.ncbi.nlm.nih.gov/projects/Sequin/]
and subsequently used to construct the genomic maps with the
help of EasyFig v. 2.1 [49].
Comparison of phage genomes and phylogenetic study
DNA homology of phage genomes on nucleotide level was
compared by EMBOSS stretcher [50,51]. A phylogenetic analysis
based on RNA-polymerase was performed by the maximum-
likelihood method, using MEGA5 [52]. The sequences of 19
phage RNA-polymerases with the following accession numbers
were used: A. baumannii phages AB3 (NCBI accession No.
YP_008060148) and phiAB1 (ADQ12732), Vibrio parahaemolyti-
cus phage VP93 (YP_002875649), Enterobacteria phages T3
(CAC86264), T7 (AAA32569) and SP6 (NP_853568), Yersinia
phage QA1122 (AAP20500), Erwinia amylovora ERA103
(YP_001039639), Prochlorococcus phage P-SSP7 (YP_214191),
Ralstonia phage RSB1 (YP_002213715) Pseudomonas putida
phage gh-1 (NP_813747), Pseudomonas aeruginosa phages
LKA1 (CAK25005), phi-2 (YP_003345489), LKD16
(YP_001522818), phikF77 (YP_002727849), phiKMV
(NP_877465), PT5 (ABW23108), PT2 (ABY70996) and LUZ19
(YP_001671971).
Proteome analysis of phages
Proteome analysis was performed on phage proteins obtained
by methanol-chloroform extraction (1:1:0.75, v/v/v) from cesium
chloride purified phage suspension, according to Moak &
Molineux [53]. Protein pellets were resuspended in SDS-PAGE
buffer (1% sodium dodecyl sulphate (SDS), 6% sucrose, 100 mM
1,4-dithiothreitol (DTT), 10 mM Tris, 0.0625% bromophenol
blue, pH 6.8) and boiled at 95uC for 3 minutes. The samples were
loaded on standard 12% polyacrylamide gel. After visualization by
staining with Simply Blue TM Safe Stain (Invitrogen Ltd, Paisley,
UK), the different protein bands were isolated. An in-gel digestion
of the proteins was performed with trypsin by overnight incubation
at 37uC. The resulting peptides were extracted from the gel by
three successive rounds of sonication and analyzed using
electrospray ionization-tandem mass spectrometry (MS/MS) as
described previously by Lavigne et al. [54]. The obtained spectra
were screened against a database containing all predicted protein
sequences. The used identification parameters were ‘minimum of
two peptides found per protein’, with a combined ‘protein
identification probability’ of at least 99.8% and a ‘best peptide
identification probability’ of 95%.
Nucleotide sequence accession numbers
The genome sequences of Acibel004 and Acibel007 phages
were submitted to GeneBank. Assigned accession numbers are
KJ473422 for Acibel004 and KJ473423 for Acibel007.
Ethics statement
No official permission was required to make waste water
sampling in Ghent University Hospital.
Results and Discussion
A. baumannii has been listed by the Infectious Diseases Society
of America (IDSA) as one of the six top-priority dangerous
microorganisms [55]. It has even been suggested that we are closer
to the end of the antibiotic era with Acinetobacter than with
methicillin-resistant Staphylococcus aureus [56]. The increased
occurrence of A. baumannii MDR strains in the Burn Wound
Center of Queen Astrid Military Hospital (Brussels, Belgium) and
in health care settings worldwide in general [9,16] prompted us to
search for alternative solutions to the problem, such as bacterio-
phages.
Establishing the A. baumannii phage collection and
characterization of bacterial strains
A total of 26 phages were isolated from the GUH wastewater
samples using various combinations of A. baumannii clinical
strains (in total 28 strains). Based on genotyping and host range
(see below), Acibel004 and Acibel007 phages were selected for
further characterization. A. baumannii clinical strain 070517/
0072, isolated from the nose of a patient in Queen Astrid Military
Hospital, showed the highest susceptibility to both phages and was
chosen as the host strain for further propagation of the phages.
The host range of the newly isolated phages was studied on a
collection of strains including the 28 clinical A. baumannii strains
and other representatives of the genus Acinetobacter, in particular
four A. pittii and two A. nosocomialis strains of clinical origin
(Table S1). All bacterial strains used in the study were
characterized according their susceptibility profiles towards four
classes of antibiotics, i.e. aminoglycosides, quinolones, carbape-
nems and polymyxins (with colistin as the only representative).
Generally, carbapenems and polymyxins are considered as last
resort antibiotics against MDR A. baumannii infections. At the
same time well-known nephrotoxicity and neurotoxicity of
polymyxins makes their application less favorable and is regarded
as a last remaining option. The most common mechanism of A.
baumannii resistance to carbapenems involves the ability to
synthesize carbapenem-hydrolyzing class D b-lactamases (CHDL).
The CHDLs of A. baumannii are divided into five phylogenetic
subgroups: OXA-23-like, OXA-40-like, OXA-51-like, OXA-58-
like and OXA-143-like carbapenemases. Recently, a new OXA-
235-like CHDL has been reported [57]. The presence of a blaOXA-
51-like CHDL gene is considered intrinsic for A. baumannii,
because of its chromosomal location and its presence in the
Two Novel Phages of A. baumannii
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Finder [www.ncbi.nlm.nih.gov/projects/gorf, accessed on  July 20,
majority of isolates of A. baumannii. The genes of the other four
established CHDL groups are mostly found on plasmids and are
considered as acquired genes. Indeed, the strains of A. pittii and A.
nosocomialis used in the study, phenotypically sensitive to all
representatives of four tested classes of antibiotics, were negative
for blaOXA-51-like CHDL encoding genes, while all 28 strains of A.
baumannii comprised blaOXA-51-like CHDL encoding gene in
their genomes (Table S1). However, the presence of the blaOXA-51-
like CHDL gene is not an unambiguous indicator of carbapenem-
resistance in A. baumannii strains, because the resistance occurs
only when the insertion sequence ISAba1 is present upstream of
the gene [28]. According to Yang et al. [5], acquired subgroup of
blaOXA-23-like carbapenemase genes are more likely to contribute
to the carbapenem resistant phenotype of strains, although silent
presence of the gene due to the lack of insertion sequences is not
unusual among A. baumannii strains of clinical origin [58,59].
Two thirds of A. baumannii strains in the study (18 out of 28) were
resistant to carbapenems, and 16 out of these 18 carbapenem
resistant strains were positive for the blaOXA-23-like carbapenemase
gene presence. Exceptions included: strain 080502/0184 positive
for the blaOXA-23-like CHDL gene but sensitive to carbapenem
and two strains (NCTC 13423 and LUH 5875 (European
epidemic clone III)) negative for the blaOXA-23-like CHDL gene
but resistant to carbapenem. Carbapenem-susceptibility of the
strain 080502/0184 can be explained by the absence of insertion
sequence ISAba1 in upstream position of blaOXA-23-like CHDL
gene as mentioned above [58,59]. In case of the strains NCTC
13423 and LUH 5875 (European epidemic clone III) it is known
that carbapenem resistance is expressed due to the insertion
sequence ISAba1 linked to blaOXA-51-like CHDL gene in upstream
position [28,60]. Most of the studied A. baumannii strains were
also characterized by resistance to aminoglycosides and quinolones
and all of them revealed susceptibility to colistin.
All 34 strains of Acinetobacter spp. were typed by rep-PCR
(DiversiLab Acinetobacter 3.4 kit BioMe´rieux) and 15 different
profiles were identified (Table S1). Four profiles within the A.
baumannii were represented with more than one strain. Within
each profile, the strains shared several features, including the
presence or absence of the blaOXA-23-like and blaOXA-51-like
CHDL genes, and antibiotic and phage susceptibility. However,
limited variability was observed in three groups representing
different rep-profiles. Only one strain out of three with rep-profile
4 revealed resistance to carbapenem and susceptibility to phage
Acibel004. Two strains with rep-profile 8 differed from each other
by susceptibility to quinolones and phage Acibel004 (Table S1).
The rep-profile 11 was the largest group and comprised 12 strains.
One strain from this group lacked the blaOXA-23-like CHDL gene.
Two strains, including the strain without blaOXA-23-like CHDL
gene, showed carbapenem-susceptibility, while the second one was
resistant to Acibel004. Acibel007 was only able to adsorb but not
to propagate on two other strains from the group and the rest 9
strains were susceptible to both phages.
Host range study of phages
All six non A. baumannii strains (4 A. pittii and 2 A.
nosocomialis) were resistant to the newly isolated phages Acibel004
and Acibel007. However, Acibel004 still showed weak adsorption
on all strains except for one A. pittii strain.
Both phages were able to propagate on approximately half of
the tested A. baumannii strains (15 out of 28), each phage was able
either to adsorb and/or propagate on 11 strains but 2 strains
showed complete resistance to both phages. Phage Acibel004 is
able to adsorb on 89.2% of 28 tested A. baumannii strains and to
propagate on 75.0% of them, whereas phage Acibel007 adsorbs to
71.4% and propagates on 60.7% of the strains (Fig. 1). Based on
the host range studies, the newly isolated phage Acibel007 can be
considered as strictly specific towards A. baumannii, while
Acibel004 is a phage which propagates only in A. baumannii
strains but still maintains weak adsorption activity on the strains of
A. pitti and A. nosocomialis. At the same time, no correlation was
detected between phage susceptibility, antibiotic resistance and
rep-pcr profile affiliation of the clinical strains used in the study.
The range of EOP for Acibel004 phage on susceptible A.
baumannii strains varied between 1.0–1.025, and for Acibel007
between 6.2521–6.2522 (Table S1). Therefore, taking into account
the measured EOP, Acibel007 can be considered as a phage with
higher lytic activity than Acibel004, despite its more limited host
range.
Phenotypic characterization of phages
Acibel004 and Acibel007 phages form clear plaques on the host
strain, differing in size. Acibel004 phage forms plaques with a
diameter of 1–2 mm, compared to 3–5 mm for Acibel007. Phage
particle morphology examined by TEM revealed that Acibel004
and Acibel007 can be assigned to different families of the order
Caudovirales (Fig. 2). Acibel004, with a 70 nm icosahedral head
and a 105 nm long contractile tail, is classified as morphotype A1
of the Myoviridae, while Acibel007, with a 60 nm head and a
10 nm long noncontractile tail, belongs to morphotype C1 of the
Podoviridae.
The frequency of appearance of phage-resistant mutants in
phage-sensitive strains is one of the characteristics of major
importance for therapeutic bacteriophages. In case of the newly
isolated phages Acibel004 and Acibel007, the mutation frequency
parameters in the host strain A. baumannii 070517/0072 are
1.260.561027 and 3.061.561026, respectively. These figures
indicate a low ability of the strain to obtain phage-resistance
mutants.
The phage adsorption and single-step growth processes were
studied to obtain an overall impression of the phage infection
cycle. Acibel004 phage achieves a maximal adsorption of 85%
within 15 min (Fig. 3A). A maximum of 95% of the Acibel007
phage particles absorb on the host strain within 10 min (Fig. 3B).
Adsorption velocity constants for Acibel004 and Acibel007 equal
to 1.261029 and 1.761029 ml/min, respectively.
The single-step growth experiments were performed for
determination of latent periods and burst sizes of phages, as
important characteristics of phage infection process. The latent
Figure 1. Activity of phages Acibel004 and Acibel007 on 28
A. baumannii clinical strains.
doi:10.1371/journal.pone.0104853.g001
Two Novel Phages of A. baumannii
PLOS ONE | www.plosone.org 4 August 2014 | Volume 9 | Issue 8 | e104853
period of Acibel004 is 27 min and the average burst size is 125
phage particles per infected cell. Acibel007 is characterized with a
shorter latent period of 21 min and a bigger burst size of 145
phage particles per infected host cell (Fig. 3C and 3D). The
obtained physiological parameters of the newly isolated phages
characterize them as phages with high activity against the
susceptible strains.
Activity of phages in broth culture
According to production guidelines of different phage prepara-
tions [61–64], which existed in Soviet Union in the past and exist
Figure 2. Transmission electron micrographs of phages. A) Acibel004, member of the Myoviridae family; B) Acibel007, member of the
Podoviridae family.
doi:10.1371/journal.pone.0104853.g002
Figure 3. Infection parameters of phages. A) Adsorption curve of Acibel004; B) Adsorption curve of Acibel007; C) Single-step growth curve of
Acibel004; D) Single-step growth curve of Acibel007. P-number of non-adsorbed phages, P0- initial number of phages, LP-latent period, BS-burst size.
The results are the mean values of three independent tests. Standard deviations are indicated.
doi:10.1371/journal.pone.0104853.g003
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in Georgia and Russia at present, phage titer of therapeutic
preparations is required to be expressed as activity of phages in
broth measured by the Appelmans’ method [33]. Stable activity of
phages in broth cultures represents their ability to overcome the
growth of phage-resistant mutants and gives an indication on
effective titer of therapeutic preparations to be used in future.
The ability of Acibel004 and Acibel007 to influence each other’s
activity while cultured together was tested in LB broth by the
Appelmans method along with assessment of the stability of
activity for a 24–48 hour period (Fig. 4). Even at the lowest MOI
of 0.00001, both phages succeed to maintain a lower OD600 value
of the bacterial suspension, compared to the control, i.e. a non-
infected bacterial culture: after 24 h of incubation. The OD600
value for Acibel004 equaled to 0.1360.03, for Acibel007 to
0.1860.02 and for the mixture of phages to 0.0760.01, while the
OD600 for the control corresponded to 0.4260.02 (Fig. 4A). The
mixture of both phages showed a relatively high activity in
comparison to each phage separately at all tested MOI, even after
48 h of incubation, i.e. at MOI of 0.00001 the OD600 of Acibel004
and Acibel007 separately, equaled to 0.2360.02 and 0.2560.03,
respectively, while the OD600 of both phages was 0.0960.01
against 0.8360.06 of the control (Fig. 4B). This finding indicates
that a mixture of Acibel004 and Acibel007 is more effective than
each phage separately. This could be explained by phages having
different adsorption receptors on the bacterial cell wall, so
bacterial cells have to accumulate different mechanisms of
resistance.
Stable activity of each phage in broth expressed by maintaining
OD600,0.1 after 48 h incubation at a minimum MOI of 0.01 and
increased activity during joint culturing; indicate that these two
phages are good candidates to be used in a phage cocktail
together.
Phage genome analysis and annotation
The genomes of the two newly isolated phages were typed by
fRFLP [34] along with other representatives from a collection of
A. baumannii bacteriophages, isolated during the same period. In
total, 26 phage genomes were screened based on neighbor joining
analysis and a phylogenic tree was constructed (Fig. S1). Acibel004
phage grouped within a large group of 15 myoviruses with very
similar RFLP profiles, whereas Acibel007 grouped together with
the only other podovirus presented in this collection, i.e.
Acibel020. The results of fRFLP contributed to the selection of
Acibel004 and Acibel007 as appropriate candidates for phage
therapy and supported further detailed investigation of their
genome and proteome, considering their largest host spectrum
among other members of the genetically related phage groups (Fig.
S2).
Sequencing of the genomes of Acibel004 and Acibel007
revealed that both phages have linear double-stranded DNA with
a length of 99,730 and 42,654 bp, respectively. G+C content of
the Acibel004 phage genome is 37.3%, and 41.2% for the
Acibel007 genome, i.e. values similar to the host’s average genome
G+C content of 40%. A high percentage of the genomes of these
phages, 90.4 and 93.6% of Acibel004 and Acibel007, respectively,
are represented by coding sequences.
The genome of Acibel004 encodes 156 ORFs on both strands
of the DNA molecule (Fig. 5 and Table S2), and 22 tRNAs,
localized in the genomic region between 111 and 115 ORFs.
Presence of tRNA genes in phage genomes, especially in virulent
phages (e.g. T4 like phages) is quite common phenomenon
[65,66]. Bailly-Bachet et al. [66] observed that tRNAs that are
kept in virulent phage genomes are those corresponding to codons
abundant in the phage and rare in the host. We analyzed codon
usage frequency in the genomes of Acibel004 and A.baumannii
ATCC 17978 strain [http://www.kazusa.or.jp/codon/cgi-bin/
showcodon.cgi?species = 400667]. Most of the codons (16 out of
21) to which 22 phage-encoded tRNAs are matching, appeared to
be presented with higher frequency in phage genome than in A.
baumannii (Fig. S3). Genome ends of Acibel004 were identified to
be not permutated (by Bal31 restriction, data not shown) but could
not be determined by sequencing. Transmembrane domains were
predicted in gene products of 21 ORFs (Table S2). The only one
signal peptide cleavage site was predicted in gp41. The online
accessible tools MEME/MAST and ARNOLD could detect 30
putative host-specific promoters and 13 Rho-factor-independent
terminators in the genome of Acibel004 (Table S3A and S3B). For
eight genes, a conserved upstream sequence was found (Table
S3C). The sequence was positioned between a promoter and the
Shine-Dalgarno site of the following ORF and showed a consensus
sequence of 59-AAGCAAACAACTTAAAAGG-39, which often
included the putative ribosome binding site and is found 7 to 9
nucleotides upstream of the start codon. This conserved feature is
limited to ORFs predicted in the middle region of the phage
genome, and therefore may indicate the presence of a phage
specific transcriptional regulator. The genome of Acibel004 is
organized in several functional modules, including nucleic acids
metabolism, early genes, tRNAs, DNA packaging, structural
proteins and lysis cassette encoding modules (Fig. 5).
The genome of Acibel007 contains 53 predicted ORFs (Fig. 6
and Table S4), all of them situated on the positive strand. No
Figure 4. Stability of activity of phages in LB broth media. A)
Study of phage activity after 24 hours; B) Study of phage activity after
48 hours. Control: non-infected bacterial culture of A. baumannii strain
070517/0072. The results are the mean values of three independent
tests. Standard deviations are indicated.
doi:10.1371/journal.pone.0104853.g004
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potential tRNA coding genes were found in the genome of
Acibel007. Gene products of five ORFs may contain transmem-
brane domains but no signal peptide cleavage site was predicted in
any of identified hypothetical proteins. Most of the identified
proteins of Acibel007 showed similarity to proteins of phages
belonging to the genus of the phiKMV-like phages of Auto-
graphivirinae subfamily. Bacteriophages belonging to the Phikmv-
likevirus genus, are known to have direct terminal repeats (DTRs)
which serve in the circularization of the phage genome after
infection. Efforts to determine the direct terminal repeats in
Acibel007 via direct sequencing were made, but failed.
Gene clustering and genome organization of Acibel007 are also
similar to those typical for phages from the Phikmvlikevirus genus.
In particular three distinct gene clusters could be identified: early
genes, genes associated with DNA metabolism and genes coding
for virion assembly, structural proteins and proteins involved in
host lysis. The gene clusters are divided by 2 putative host-specific
and 5 phage-specific promoters and 2 putative Rho-factor
independent terminators (Fig. 6, Tables S5A, B and C). The
early genes cluster in Acibel007 encodes 15 small proteins with no
similarity to other gene products in Genebank database with only
one exception for gp1. Gene product 1 corresponding proteins can
be found in all phiKMV-like phages suggesting strongly conserved
function of this protein in phage infection or host conversion.
Presence and order of the genes in the nucleic acids metabolism
associated genes cluster correspond to others found in phiKMV
like phages. However one major difference can be detected:
gp31encoded in front of RNA polymerase gene has predicted
function of dNMP kinase, an enzyme necessary for the rapid
synthesis of the bacteriophage DNA in large amounts. This
enzyme is not presented in any of phiKMV-like phages active
against P. aeruginosa and other bacterial species except A.
baumannii phages (phiAB1, AB3, Abp1). However the presence of
dNMP is not unusual for the representatives of T7likevirus genus
of Autographivirinae subfamily, the gene coding this putative
enzyme can be found in the genomes of gh-1 and other similar to
gh-1 phages. Gene product 31 of Acibel007 showed high similarity
to the putative kinases encoded by the above A. baumannii phages
and moderate similarity to kinase of T5 Enterobacteria phage,
similarity is high especially close to enzyme’s N-termini region.
Phage encoded dNMP kinases are mostly characterized by broad
substrate specificity. Using either ATP or dATP as the phosphate
donor, kinases of well-known T4 and T5 Enterobacteria phages
catalyze the phosphorylation of 3 and 4 deoxynucleoside
monophosphates, respectively [67]. Further tests need to be done
to define whether Acibel007 encoded dNMP kinase also presents
enzyme with broad substrate specificity.
One more difference in genome organization of phiKMV-like
phages active against A.baumannii and other bacterial species, is
presented by relocation of maturase genes from after lysis genes
cassette position into the front of it. Also no Rz/Rz1 genes
common part of lysis cassette in phiKMV-like phages [68] have
been identified in Acibel007 and other related Acinetobacter
phages yet.
Proteome analysis of phages
SDS-PAGE and mass spectrometric analysis of purified phage
particles of Acibel004 and Acibel007 were performed for the
identification of structural phage proteins and to confirm gene
predictions based on BLASTP homology search. After protein
electrophoresis of the isolated Acibel004-proteins, ten protein
bands could be visualized on gel with molecular weights ranging
from 15 to 95 kDa. ESI-MS/MS analysis revealed the presence of
26 proteins (Table S6A). For 12 of these proteins, a structural
Figure 5. Genome map of Acibel004. tRNAs are indicated with yellow bars, putative host-specific promoters and Rho-factor independent
terminators with red and blue triangles, respectively. PRP: phosphoribosylpyrophosphate, NPR: nicotinamide phosphoribosyl.
doi:10.1371/journal.pone.0104853.g005
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function could be predicted based on homologous proteins found
via BLASTP, while no function could be predicted for 11 other
proteins. Seven proteins out of the above 11 located in the cluster
of structural proteins will be assigned to be part of the phage
particle structure based on these results. Three additional proteins
out of total 26 (gp056, gp062 and gp066) are significantly present,
but their predicted function is related to enzymatic activity of
phages. The presence of these proteins in the structural proteome
of phage Acibel004 could point out that they are needed in the
early infection cycle and enter the cell together with the phage
DNA upon infection of the bacterium. Only one protein (gp118)
with a predicted structural function could not be identified by
proteomics.
For Acibel007, 11 proteins were identified via ESI-MS/MS
(Table S6B). For all except three of these proteins, a structural
function was predicted via BLASTP homology search. These three
unknown proteins (gp03, gp04, gp24) could be assigned to the
early and nucleic acids metabolism regions of the phage genome.
This can indicate that these proteins are essential in the first steps
of the infection process, and are therefore included in the phage
particle. One protein with a predicted structural function, (gp42)
could not be detected via mass spectrometry.
Comparative genomics and proteomics
The detailed genome analysis of Acibel004 showed that it
represents a novel phage of A. baumannii. However, some of the
structural proteins showed high similarity to the partially
sequenced A. baumannii phage Abp53 [69]. Most of the
annotated proteins encoded by Acibel004 also showed similarity
to putative proteins of P. aeruginosa phages PAK-P1, PAK-P3
and KPP10, mostly including structural and hypothetical proteins
with no defined functions Some enzymes such as DNA/RNA
helicase, exodeoxyribonuclease and others also share similarity
(Table S2). All three P. aeruginosa phages are strongly lytic phages
and have been used in a number of phage therapy studies. In
particular, phages PAK_P1 and PAK_P3 have been applied to
combat lung infections in mice with successful therapeutic
outcomes [70,71], while KPP10 was also successfully used for
treatment of gut-derived sepsis in mice [72]. The genome
comparison performed by EMBOSS stretcher [50,51] showed
47.1, 46.0 and 45.9% DNA homology of Acibel004 towards PAK-
P1, PAK-P3 and KPP10, respectively. The genome organization
of Acibel004 and the above phages carry some differences as well.
Nucleic acids metabolism genes in Acibel004 are localized in a
single large module while in the above phages it is divided by the
region of early genes into two modules: a nucleotide metabolism
module and a DNA replication/transcription associated genes
modules [73]. In Acibel004 DNA metabolism associated and DNA
packaging/structural proteins modules are separated by large
region of more than 20 kbp length encoding proteins with no
defined function, presumably the early genes region and tRNAs
encoding genes. Most of the transcription regulatory elements are
also accumulated in this region (Fig. 5).
Acibel007, like all other phages from the subfamily of the
Autographivirinae encodes an RNA polymerase in its genome. For
the phiKMV-likes, this RNA polymerase is situated at the end of
the DNA replication region. Based on the sequence of RNA
polymerases from the other 19 representatives of this subfamily, a
phylogenetic tree was constructed (Fig. 7). As expected, Acibel007
grouped with the other A. baumannii phages included, i.e. phiAB1
and AB3, also showing strong relatedness to unclassified phiKMV-
like phage VP93 active against Vibrio parahaemolyticus. At the
DNA level, Acibel007 showed 54.7% similarity to phiAB1, and
46.2% to phiKMV.
No genes associated with pathogenicity/virulence or lysogeny
(e.g. integrase encoding) were identified in the genomes of
Acibel004 and Acibel007. The results mentioned in this study
are clear indicators that both of these phages are good candidates
for use in phage therapy against drug-resistant A. baumannii
infections.
Conclusions
The newly isolated A. baumannii phages Acibel004 and
Acibel007 are characterized by a broad host range, a relatively
low frequency of occurrence of phage-resistant mutant bacterial
cells and infection parameters required by therapeutic phages in
general. Close genetic relatedness of the studied phages to well-
known groups of lytic phages together with the absence of the
genes associated with lysogeny indicates a true virulent nature of
these phages.
Figure 6. Genome map of Acibel007. Putative host-specific and phage-specific promoters and Rho-factor independent terminators are indicated
with red, yellow and blue triangles, respectively.
doi:10.1371/journal.pone.0104853.g006
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In conclusion, Acibel004 and Acibel007, based on thorough
characteristic of their physiology, genome and proteome, can be
regarded as phages with a high potential to be applied for
bacteriophage-based therapy against infections caused by A.
baumannii strains. Further in vivo safety and efficacy of these
phages produced as a therapeutic preparation need to be
evaluated in clinical trials.
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